NEWS CENTER
Poseida News Center
Featured Content
Read media coverage on Poseida, find resources for the working press, and get insights from our executive leadership team on how Poseida is advancing a new class of cell and gene therapies.
Poseida in the News
Approaching The Allogeneic Tipping Point: The Emergence Of Allogeneic Cell Therapy For Oncology
|
November 1, 2023
Talking allo CAR-T and seeing how it is manufactured at Poseida
|
October 31, 2023
Interview with Dr. Kristin Yarema, President of Cell Therapy at Poseida Therapeutics – Xtalks Life Science Podcast Ep. 129
|
September 27, 2023
Astellas in $50m allogeneic CAR-T deal with Poseida
|
August 14, 2023
Poseida lines up another allogeneic CAR-T partner, allying with Astellas on solid tumors
|
August 7, 2023
Executive Perspectives
Press Releases
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023
|
November 9, 2023
Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition
|
November 2, 2023
Poseida Therapeutics Announces Leadership Transition
|
October 9, 2023
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
|
September 5, 2023
Media Library
Usage rights & restrictions:
These media assets are free for editorial broadcast, print, online and radio use. They are restricted for other purposes.
